R&D Trends

Biologic drugs market about to soar

Wednesday, June 20, 2012 11:29 AM

EvaluatePharma, a company providing pharmaceutical and biotechnology sector analysis and consensus forecasts, has released a report titled “Surveying Tomorrow’s BioPharma Landscape: The NASDAQ Biotech Index Up Close,” which shows that the quantity of biologic drugs on the market will likely soar by 2018.

More... »

Ambrx, Merck collaborate to develop biologic drug conjugates

Monday, June 18, 2012 03:21 PM

Ambrx, a La Jolla, Calif.-based clinical-stage biopharmaceutical company, has entered into a collaboration with Merck to design and develop rationally optimized biologic drug conjugates based on Ambrx's site-specific protein medicinal chemistry technology.

More... »

Scotland-based Innova Partnerships opens Boston office

Friday, June 15, 2012 12:02 PM

Innova Partnerships, a Scottish life sciences partnering and investment company, has opened of its first U.S. venture in Northborough, Mass., to enable the company to play a key role in the internationalization of life science companies in Scotland.

More... »

First MDS consortium to conduct trials and research to improve patient outcomes

Thursday, June 14, 2012 09:23 AM

Taussig Cancer Institute at Cleveland Clinic will participate in an unprecedented, six-institution consortium designed to conduct clinical trials and research to improve outcomes for patients with myelodysplastic syndrome (MDS).

More... »

Astellas, DNDi collaborate on drug discovery research treating NTDs

Wednesday, June 13, 2012 09:08 AM

Astellas Pharma of Tokyo, Japan, and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit R&D organization focused on neglected diseases, have formed a drug discovery research collaboration for leishmaniasis, Chagas disease and sleeping sickness — three neglected tropical diseases (NTDs) which together affect nearly 10 million people worldwide.

More... »

Profil Institute, Florida Hospital to establish center for metabolic research

Monday, June 11, 2012 12:16 PM

Profil Institute for Clinical Research, a company focused on early phase clinical trials for diabetes and obesity, and Florida Hospital, one of nation's largest clinical care providers, formed a joint venture to establish a state-of-the-art early phase clinical services center for metabolic disease research, including diabetes, obesity and cardiometabolic diseases.

More... »

IMI tackles health research challenges with 7 new projects

Friday, June 8, 2012 12:45 PM

The Innovative Medicines Initiative (IMI), a public-private partnership in health R&D, has successfully launched its third wave of projects. The seven new projects, which have a combined total cost of $267 million and will run for five years, are taking on some of the biggest challenges in healthcare research.

More... »

Medical discoveries contracted out as CROs move abroad

Thursday, June 7, 2012 11:09 AM

Medical devices companies are outsourcing more and more of their research and development processes, reducing costs and time by conducting overseas trials, according to a new study released by GlobalData.

More... »

PhRMA reports nearly 1,000 medicines in development to fight cancer

Monday, June 4, 2012 06:00 PM

Pharmaceutical Research and Manufacturers of America (PhRMA) has released a report on American biopharmaceutical research companies’ 981 medicines and vaccines currently in development to fight the many types of cancer affecting millions of patients worldwide.

More... »

CDRD, CDRD Ventures, GSK collaborate to advance Canadian health research

Friday, June 1, 2012 03:07 PM

The Centre for Drug Research and Development (CDRD), its commercial arm, CDRD Ventures (CVI), and global pharmaceutical company GlaxoSmithKline (GSK) in have entered into a strategic collaboration that will provide new financial resources as well as leading drug development expertise to be applied to the development and commercialization of health research conducted in Canadian research institutions.

More... »